
The Centers for Disease Control and Prevention (CDC) recommends that certain immunocompromised individuals who have already received an initial two doses of mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) receive an additional dose.
Emerging evidence shows some people who are moderately to severely immunocompromised experienced a reduced immune response to the initial COVID-19 vaccine series. The administration of an additional mRNA COVID-19 VACCINE aims to prevent serious and possibly life-threatening COVID-19 within this population.



















































